Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Comment by Momentum11on Jan 05, 2018 9:54pm
67 Views
Post# 27295402

RE:RE:RE:BIG news on NF @ CI

RE:RE:RE:BIG news on NF @ CIThey have 2.5 million cash on the books after the sale of their major facility, they just bought a business for $1 million and have not added any value.  That business is in the U.S in a state that is approaching a mature MJ market with 0 exposure to the Canadian market.

Management has failed for the past 3 years at their old business model and does not have experience in the business the have purchased.They provide no vlaue to We Are Kured

Does this sound like a company worth 33 million? If you had the option of buying We are Kured for 1 million or a company that just bought We Are Kured and has a few million dollars for 33 million would you pay the 33? 

Don't say they own the Langley property either because they do not

MJ hype is what is keeping this thing afloat, a company could have a business  wanting to extract THC for  MJ smokers human sh!t and they would be flying high.

This is a game of following the money though so base your investments on that


Bullboard Posts